1 insider has bought $76k of CVRx, Inc. shares across 1 disclosed dealing since August 2026.
| Aug 13, 2026 | Binkowski Brent — CHIEF OPERATING OFFICER | $76,432 |
CVRx, Inc. is classed as health care. By value disclosed, that ranks 36th of the 44 health care companies where insiders bought in the last twelve months.
Companies with a comparable amount of disclosed buying: BlossomHill Therapeutics, Inc. · Adagene Inc. · Guardant Health, Inc. · IMMUCELL CORP · MSA Safety Inc · PALISADE BIO, INC.
See also the biggest buys, cluster buying and the most-active companies.
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Every row is a public regulatory disclosure — a Form 4 filing with the SEC — collected within minutes of being published. We don’t take company submissions and we don’t edit the numbers; the only thing we add is the rating and the reasoning behind it.
Sometimes. A insider buying with their own money is one of the few honest signals in the market, but plenty of purchases are routine — small top-ups, scheme allocations, or a well-paid executive rounding out a holding. That’s what our six-point check is for: it separates the conviction buys from the housekeeping, and shows you which is which.
The pipeline runs every 15 minutes through the trading day, so a new disclosure appears here shortly after it’s filed. Company stats refresh daily.
Yes — that’s what the app is for. Follow CVRx, Inc. and you’ll get a push the moment a insider files, with the full analysis attached, plus alerts if the price moves after a buy you’re following.
No. ddbx rates the conviction behind insider buys and shows the reasoning. It’s information, never a recommendation, and never a guarantee. What you do with it is your call.